The ovarian remnant syndrome and ureteral obstruction: medical management.
The ovarian remnant syndrome represents the development of symptoms due to residual ovarian tissue after bilateral salpingo-oophorectomy. Treatment generally consists of surgical resection but recurrence after resection is common. A case is reported in which a postoperative recurrent ovarian remnant was successfully managed by using a luteinizing hormone-releasing hormone agonist. In addition, this report includes a survey of gynecologists to determine the frequency of this syndrome and of ureteral involvement.
Koch
M O
MO
Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2765.
Coussens
D
D
Burnett
L
L
D000328:Adult; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D006801:Humans; D015994:Incidence; D016729:Leuprolide / Q000627:therapeutic use*; D010052:Ovariectomy; D010053:Ovary; D011183:Postoperative Complications / Q000188:drug therapy* / Q000453:epidemiology; D013577:Syndrome; D014517:Ureteral Obstruction / Q000188:drug therapy / Q000209:etiology*
D016729:Leuprolide